Sarah Rue,Brendan Eckelman,Quinn L. Deveraux,Marc Nasoff
申请号：
US15685257
公开号：
US20170355775A1
申请日:
2017.08.24
申请国别(地区):
US
年份:
2017
代理人:
摘要：
This disclosure relates to immunogens and monoclonal antibodies useful in the identification and/or treatment of cancer cells, including those of the dog. In one example, chimeric anti-canine CD20 antibodies are provided. The antibodies can be used therapeutically to treat lymphoma in dogs.
